Allergies News and Research

Latest Allergies News and Research

UVA Health increasing access to food allergy clinical trials and expanding research

UVA Health and UVA Children's are increasing access to the latest food allergy clinical trials and expanding their cutting-edge food-allergy research, following their selection to a national food-allergy clinical network.

10 Jun 2020

Old antibiotic may be a powerful new tool against deadly superbug

USC researchers have discovered that an old antibiotic may be a powerful new tool against a deadly superbug, thanks to an innovative screening method that better mimics conditions inside the human body.

8 Jun 2020

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Dr. Leszek Ignatowicz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $1.95 million federal grant to study what causes autoimmunity in the human body.

8 Jun 2020

Actual mortality rate of COVID-19-affected adults is less than what was previously reported

An online first study published in Critical Care Medicine indicates the actual mortality rate of adults with critical illness from COVID-19 is less than what was previously reported.

5 Jun 2020

Study: Eggs can be used as low-cost coating to protect fruits and vegetables

Eggs that would otherwise be wasted can be used as the base of an inexpensive coating to protect fruits and vegetables, according to Rice University researchers.

5 Jun 2020

Next-generation sequencing of COVID-19 virus offers powerful metagenomic data

Next-generation sequencing of the COVID-19 virus is providing powerful metagenomic data, which, combined with clinical data, will inform the search for effective treatments, as reported in the peer-reviewed journal Pediatric Allergy, Immunology, and Pulmonology.

4 Jun 2020

Assessing the integrity of remdesivir clinical trial during COVID-19 pandemic

As acknowledged in the first remdesivir double-blind placebo-controlled clinical trial addressing treatment for COVID-19 recently published in Lancet (Wang, et al., April 29, 2020), a statistician at Rutgers Cancer Institute of New Jersey was called on to guard the integrity of that trial.

4 Jun 2020

New research focuses on protein-coding gene's role in inflammatory bowel disease

A protein-coding gene associated with autoimmune diseases such as Crohn's disease and ulcerative colitis, collectively referred to as inflammatory bowel disease, or IBD, will be the focus of new research in the School of Medicine at the University of California, Riverside.

4 Jun 2020

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

Eli Lilly and Company today announced patients have been dosed in the world’s first study of a potential antibody treatment designed to fight COVID-19.

4 Jun 2020

New drug can prevent life-threatening anaphylaxis, shows study

For someone with a food or drug allergy, the risk of life-threatening anaphylactic shock lurks around every corner. A new Northwestern Medicine study shows there might be a pill that can be taken proactively to prevent mild to life-threatening anaphylaxis, no matter the cause.

3 Jun 2020

Bacteria that live in soil and on people have extensive antibiotic-destroying genes

The latest generation of tetracyclines - a class of powerful, first-line antibiotics - was designed to thwart the two most common ways bacteria resist such drugs.

3 Jun 2020

Rigidity of tissues drives immune system activity, UCLA study finds

A UCLA research team has identified a new paradigm for understanding the regulation of the immune system, potentially paving the way for new approaches to treating infections and immune-related diseases such as type 1 diabetes and certain cancers.

2 Jun 2020

A new tool to help biomedical scientists better understand COVID-19 virus

Biomedical scientists working with COVID-19 have a new tool to help them better understand the virus and feel confident about the structural models they are using in their research.

2 Jun 2020

ISSCR 2020 Virtual Meeting to deliver comprehensive scientific education program

The International Society for Stem Cell Research has transformed its annual scientific meeting into a virtual experience, bringing the global stem cell community together to share knowledge, collaborate, and network.

2 Jun 2020

Study maps novel coronavirus infection in cells of nasal cavity, airway and lungs

In a major scientific study published in the journal Cell, scientists at the UNC School of Medicine and the UNC Gillings School of Global Public Health have characterized the specific ways in which SARS-CoV-2 – the coronavirus that causes COVID-19 – infects the nasal cavity to a great degree – replicating specific cell types – and infects and replicates progressively less well in cells lower down the respiratory tract, including the lungs.

1 Jun 2020

Ruxolitinib shows promise in severe COVID-19

An anti-inflammatory drug Ruxolitinib has shown promising results in the treatment of severe coronavirus disease COVID-19. The study titled, “Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial,” was published as a pre-proof for the Journal of Allergy and Clinical Immunology.

31 May 2020

Allergies News and Research

Latest Allergies News and Research

UVA Health increasing access to food allergy clinical trials and expanding research

Old antibiotic may be a powerful new tool against deadly superbug

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Actual mortality rate of COVID-19-affected adults is less than what was previously reported

Study: Eggs can be used as low-cost coating to protect fruits and vegetables

Next-generation sequencing of COVID-19 virus offers powerful metagenomic data

Assessing the integrity of remdesivir clinical trial during COVID-19 pandemic

New research focuses on protein-coding gene's role in inflammatory bowel disease

World’s first study of potential antibody therapy to fight COVID-19 begins in humans

New drug can prevent life-threatening anaphylaxis, shows study

Bacteria that live in soil and on people have extensive antibiotic-destroying genes

Rigidity of tissues drives immune system activity, UCLA study finds

A new tool to help biomedical scientists better understand COVID-19 virus

ISSCR 2020 Virtual Meeting to deliver comprehensive scientific education program

Study maps novel coronavirus infection in cells of nasal cavity, airway and lungs

Ruxolitinib shows promise in severe COVID-19

Chimeron Bio and George Mason NCBID partner to develop a coronavirus vaccine

5-day Remdesivir dose works as well as the 10-day dose in COVID-19, study finds

Transgenic mouse model of HLH may play key role in saving lives during COVID-19

Investigational antiviral superior to standard of care for treating COVID-19 patients

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Allergies News and Research

Latest Allergies News and Research

Forensics and toxicology - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in